The global preclinical imaging market is experiencing steady growth, driven by rising investments in pharmaceutical research and development (R&D), increasing demand for advanced drug discovery tools, and continuous technological advancements in biomedical imaging. According to Grand View Research, the market is expanding as pharmaceutical companies, biotechnology firms, and research institutions increasingly adopt sophisticated imaging technologies to evaluate disease progression, assess treatment effectiveness, and improve drug development processes. Growing emphasis on precision medicine, non-invasive imaging techniques, and translational research is further supporting market expansion.

Preclinical imaging technologies enable researchers to observe biological processes, disease progression, and treatment responses in laboratory models before therapies advance to human clinical trials. These technologies support research in oncology, neurology, cardiology, immunology, and infectious diseases. Increasing investment in drug development, the growing need for non-invasive imaging, and advancements in image analysis are strengthening demand for preclinical imaging equipment and related services.

Key Market Metrics

• Market Size in 2025: USD 1.0 billion.

• Estimated Market Size in 2026: USD 1.1 billion.

• Projected Market Size by 2033: USD 1.6 billion.

• Forecast CAGR: 5.6% from 2026 to 2033.

• Dominant Region: North America accounted for 46.4% of global market revenue in 2025.

Download a free sample copy of the Preclinical Imaging Market report to understand detailed coverage and inclusions in the final report

Market Growth Drivers and Restraints

Market Drivers

• Rising Investments in Pharmaceutical R&D: Pharmaceutical and biotechnology companies are investing in new drug candidates, vaccines, and advanced therapies. Preclinical imaging helps researchers assess treatment responses, investigate biological targets, and evaluate drug behavior before clinical testing.

• Increasing Prevalence of Chronic Diseases: Cancer, cardiovascular disorders, and neurodegenerative diseases are increasing the need for innovative treatments. Preclinical imaging allows researchers to monitor disease development and evaluate therapeutic effectiveness in laboratory models.

• Advancements in Imaging Technologies: Improvements in magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), single-photon emission computed tomography (SPECT), and optical imaging are enhancing image quality and research capabilities.

• Growing Demand for Non-Invasive Research: Imaging enables repeated observation of the same animal model over time, supporting longitudinal studies and potentially reducing the number of animals needed for certain experiments.

• Expansion of Translational Research: Greater collaboration among academic institutions, research laboratories, CROs, and drug developers is increasing the need for sophisticated imaging equipment and specialized analytical services. 

Market Restraints

• High Equipment Costs: Advanced imaging platforms require substantial initial investment, making acquisition challenging for smaller laboratories and research institutions.

• Complex Regulatory Requirements: Imaging agents, research protocols, and laboratory practices must meet applicable regulatory and ethical standards, potentially increasing costs and development timelines.

• Animal Welfare Considerations: Restrictions on animal research and the development of alternative methods, including in-vitro testing and computational models, may affect demand for some preclinical imaging applications.

• Specialized Expertise Requirements: Operating advanced imaging systems and interpreting complex results often requires trained personnel, adding to laboratory operating costs.

Segment Analysis

By Type

The preclinical imaging market includes imaging modalities, reagents, and services.

• Modality: This segment dominated the market with 63.92% of revenue in 2025. It includes systems such as MRI, micro-CT, PET, SPECT, optical imaging, and ultrasound. These technologies help researchers visualize anatomical structures and biological activity in laboratory models. 

• Reagents: Imaging reagents and contrast agents support the visualization of specific biological targets and processes. Their use depends on the imaging modality, research objective, and biological characteristics being investigated.

• Services: Preclinical imaging services include image acquisition, data processing, quantitative analysis, and interpretation. The service segment is expected to grow rapidly as research organizations seek specialized expertise and access to advanced imaging capabilities without purchasing and maintaining every system themselves. 

By Application

- Disease Mechanism and Pathophysiology Studies: This application segment held the largest market share in 2025. Imaging systems help researchers study disease progression, tumor development, inflammation, neurological changes, and cardiovascular abnormalities. Repeated imaging can provide insights into biological changes over time and support the evaluation of experimental treatments. 

- Drug Discovery and Development: This segment is projected to register the fastest growth during the forecast period. Preclinical imaging supports target validation, drug distribution studies, treatment-response monitoring, and evaluation of potential toxicity. By generating information about biological activity in living models, imaging can help researchers assess drug candidates before advancing them into clinical development.

- Basic and Translational Research: Imaging tools help researchers investigate fundamental biological mechanisms and connect laboratory findings with potential clinical applications. They are used across oncology, immunology, neurology, cardiology, and infectious disease research.

By End Use

• Pharmaceutical and Biotechnology Companies: These companies held the largest end-use share in 2025. Their demand is supported by ongoing drug development programs, investments in advanced therapies, and the need to evaluate potential treatments before human trials.

• Contract Research Organizations (CROs): CROs are expected to experience the fastest growth as drug developers increasingly outsource preclinical research. CROs offer specialized equipment, experienced personnel, and imaging analysis capabilities that can help clients manage research costs and timelines.

• Academic and Research Institutions: Universities and research centers use preclinical imaging to study disease mechanisms, investigate new treatment approaches, and conduct collaborative biomedical research. Public funding and research partnerships can support investment in these facilities.

Go Deeper! Ask Prism AI

about the Global Preclinical Imaging Market. Get instant answers to

questions related to market sizing, growth drivers & their impact, and more.

Technological Trends and Innovations

Technological development is improving the capabilities of preclinical imaging platforms and expanding their role in drug discovery.

• Artificial Intelligence and Image Analysis: AI-based tools can assist with image reconstruction, segmentation, quantification, and data interpretation. These capabilities can help researchers process complex datasets more efficiently, although performance depends on the application, data quality, and validation.

• Multimodal Imaging Systems: Hybrid platforms combine complementary technologies, such as PET/CT or PET/MRI, to provide anatomical and functional information. This enables researchers to examine multiple aspects of a biological process within a coordinated workflow.

• High-Resolution Imaging: Advances in micro-MRI, micro-CT, and ultrasound are supporting detailed visualization of tissues and organs in small-animal models.

• Advanced Optical Imaging: Fluorescence and bioluminescence techniques allow researchers to monitor molecular activity and selected biological processes in living models.

• Specialized Imaging Services: Growing demand for image acquisition, processing, and quantitative analysis is creating opportunities for service providers with advanced equipment and experienced scientific teams.

These innovations are helping laboratories improve data quality and gain deeper insights into disease biology and therapeutic performance. 

Regional Market Insights

- North America: North America dominated the global preclinical imaging market with 46.42% of revenue in 2025. Strong pharmaceutical R&D investment, advanced research infrastructure, government funding, and the presence of established technology providers support the region's leading position. The United States is a major contributor because of its extensive network of biotechnology companies, academic laboratories, and CROs. 

- Europe: The European market benefits from pharmaceutical research, university-led biomedical studies, and investments in translational medicine. Demand for imaging technologies is also influenced by animal welfare requirements and the need for reliable, reproducible preclinical research data.

- Asia Pacific: The region offers growth opportunities as pharmaceutical and biotechnology companies increase R&D spending and research infrastructure expands. China, Japan, and India are important markets for advanced imaging equipment and related services. India's preclinical imaging market is projected to grow at a CAGR of 7.7% from 2026 to 2033, reaching USD 63.2 million by 2033. 

- Latin America: Market development is supported by growing research activity, expanding healthcare capabilities, and demand for improved biomedical research infrastructure.

- Middle East & Africa: Research investment, academic partnerships, and the gradual expansion of life sciences capabilities offer opportunities for preclinical imaging suppliers, although access to expensive equipment can vary considerably across countries.

Looking for more specific insights? Customize this report to suite your business needs

Competitive Landscape

The global preclinical imaging market includes scientific equipment manufacturers and life sciences companies competing through product innovation, system performance, software development, and research partnerships.

Key companies operating in the market include:

• Cubresa Inc.

• Bruker Corporation

• Revvity, Inc.

• FUJIFILM VisualSonics

• Mediso Ltd.

• Rigaku (MILabs B.V.)

• MR Solutions

• Aspect Imaging

• TriFoil Imaging

• Siemens Healthineers

Companies are focusing on improving imaging resolution, combining multiple imaging modalities, enhancing software capabilities, and providing specialized services. Strategic acquisitions and new product launches also help companies expand their technology portfolios and strengthen their position in the market. 

About us:

Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.

Explore U.S. Healthcare Facility Mapping & Intelligence Platform - https://www.grandviewresearch.com/horizon/hospital-database